BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 97 filers reported holding BRIDGEBIO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,926,282 | +113.2% | 148,892 | +39.1% | 0.01% | +150.0% |
| Q2 2023 | $1,841,294 | -2.9% | 107,052 | -6.4% | 0.00% | -33.3% |
| Q1 2023 | $1,895,857 | +85.0% | 114,346 | -15.0% | 0.00% | +50.0% |
| Q4 2022 | $1,024,920 | -99.9% | 134,504 | +3.5% | 0.00% | 0.0% |
| Q2 2022 | $1,180,255,000 | -52.9% | 129,984 | -47.4% | 0.00% | -33.3% |
| Q1 2022 | $2,506,522,000 | +471.3% | 246,948 | +838.9% | 0.00% | +200.0% |
| Q4 2021 | $438,717,000 | -59.3% | 26,302 | +14.4% | 0.00% | -50.0% |
| Q3 2021 | $1,077,166,000 | +178.7% | 22,982 | +262.4% | 0.00% | +100.0% |
| Q2 2021 | $386,547,000 | -56.7% | 6,341 | -56.2% | 0.00% | 0.0% |
| Q1 2021 | $892,091,000 | +12.2% | 14,482 | +29.5% | 0.00% | 0.0% |
| Q4 2020 | $794,939,000 | +23.6% | 11,179 | -34.8% | 0.00% | 0.0% |
| Q3 2020 | $642,905,000 | +127.2% | 17,135 | +97.5% | 0.00% | – |
| Q2 2020 | $282,957,000 | -62.1% | 8,677 | -66.3% | 0.00% | -100.0% |
| Q1 2020 | $745,706,000 | +555.2% | 25,714 | +691.9% | 0.00% | – |
| Q4 2019 | $113,807,000 | +60.7% | 3,247 | -1.5% | 0.00% | – |
| Q3 2019 | $70,808,000 | – | 3,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,835,722 | $103,449,000 | 44.18% |
| Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $995,211,000 | 12.26% |
| SC US (TTGP), LTD. | 2,544,738 | $68,632,000 | 4.69% |
| Cormorant Asset Management, LP | 2,780,885 | $75,000,000 | 4.31% |
| Perceptive Advisors | 6,706,268 | $180,868,000 | 4.15% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $717,968,000 | 3.22% |
| Hillhouse Capital Management | 2,035,790 | $54,905,000 | 1.75% |
| Alpine Group USVI, LLC | 20,000 | $539,000 | 1.70% |
| HHLR ADVISORS, LTD. | 2,352,900 | $63,458,000 | 1.42% |
| SCGE MANAGEMENT, L.P. | 588,235 | $15,865,000 | 0.79% |